Racial and ethnic differences in plasma p-tau217 ratio biomarker eligibility rates in a preclinical AD trial with lecanemab. uri icon

authors

  • Molina-Henry, Doris P
  • Grill, Joshua D
  • Johnson, Keith
  • Rissman, Robert A
  • Aisen, Paul
  • Reisa Sperling, MD
  • Raman, Rema
  • Liu, Andy
  • Langford, Oliver
  • Braunstein, Joel B
  • Verghese, Philip B
  • Venkatesh, Venky
  • Dhadda, Shobha
  • Irrizary, Michael

publication date

  • August 22, 2025